Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 597-601

  Strandberg, Kristi L ^a   Peterson, Marnie L ^b   Lin, Ying Chi ^b   Pack, Melinda C ^c   Chase, David J ^c   Schlievert, Patrick M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GLYCEROL MONOLAURATE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GARDNERELLA VAGINALIS; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS; MONKEY; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VAGINA FLORA; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; GARDNERELLA VAGINALIS; HUMANS; LACTOBACILLUS; LAURATES; MIDDLE AGED; MONOGLYCERIDES; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 75749115115     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01151-09     Document Type: Article

References (30)

1. Alvarez-Olmos, M. I., M. M. Barousse, L. Rajan, B. J. Van Der Pol, D. Fortenberry, D. Orr, and P. L. Fidel, Jr. 2004. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex. Transm. Dis. 31:393-400.
2. Amsel, R., P. A. Totten, C. A. Spiegel, K. C. Chen, D. Eschenbach, and K. K. Holmes. 1983. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22.
3. Catlin, B. W. 1992. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin. Microbiol. Rev. 5:213-237.
4. Centers for Disease Control and Prevention. 2006. Sexually transmitted disease treatment guidelines, 2006. MMWR Recommend. Rep. 55(RR11): 1-94.
5. Eschenbach, D. A., P. R. Davick, B. L. Williams, S. J. Klebanoff, K. Young-Smith, C. M. Critchlow, and K. K. Holmes. 1989. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27:251-256.
6. Ferris, D. G., M. S. Litaker, L. Woodward, D. Mathis, and J. Hendrich. 1995. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J. Fam. Pract. 41:443-449.
7. Fleury, F. J. 1981. Adult vaginitis. Clin. Obstet. Gynecol. 24:407-438.
8. Forsum, U., E. Holst, P. G. Larsson, A. Vasquez, T. Jakobsson, and I. Mattsby-Baltzer. 2005. Bacterial vaginosis-a microbiological and immunological enigma. APMIS 113:81-90.
9. Foxman, B., J. V. Marsh, B. Gillespie, and J. D. Sobel. 1998. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J. Womens Health 7:1167-1174.
10. Gutman, R. E., J. F. Peipert, S. Weitzen, and J. Blume. 2005. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet. Gynecol. 105: 551-556.
11. Hawes, S. E., S. L. Hillier, J. Benedetti, C. E. Stevens, L. A. Koutsky, P. Wolner-Hanssen, and K. K. Holmes. 1996. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174:1058-1063.
12. Hill, G. B. 1993. The microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 169:450-454.
13. Hillier, S. L. 1998. The vaginal microbial ecosystem and resistance to HIV. AIDS Res. Hum. Retrovir. 14(Suppl. 1):S17-S21.
14. Hurley, R., and J. De Louvois. 1979. Candida vaginitis. Postgrad. Med. J. 55:645-647.
15. Kabara, J. J. (ed.). 1984. Cosmetic and drug preservation: principles and practice, vol. 1. Marcel Dekker, Inc., New York, NY.
16. Li, Q., J. D. Estes, P. M. Schlievert, L. Duan, A. J. Brosnahan, P. J. Southern, C. S. Reilly, M. L. Peterson, N. Schultz-Darken, K. G. Brunner, K. R. Nephew, S. Pambuccian, J. D. Lifson, J. V. Carlis, and A. T. Haase. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-1038.
17. Nyirjesy, P. 2008. Vulvovaginal candidiasis and bacterial vaginosis. Infect. Dis. Clin. North Am. 22:637-652.
18. O'Brien, R. F. 2005. Bacterial vaginosis: many questions-any answers? Curr. Opin. Pediatr. 17:473-479.
19. Pappas, P. G., C. A. Kauffman, D. Andes, D. K. Benjamin, Jr., T. F. Calandra, J. E. Edwards, Jr., S. G. Filler, J. F. Fisher, B. J. Kullberg, L. Ostrosky-Zeichner, A. C. Reboli, J. H. Rex, T. J. Walsh, and J. D. Sobel. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
20. Pechous, R., N. Ledala, B. J. Wilkinson, and R. K. Jayaswal. 2004. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:3057-3063.
21. Peterson, M. L., and P. M. Schlievert. 2006. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry 45:2387-2397.
22. Projan, S. J., S. Brown-Skrobot, P. M. Schlievert, F. Vandenesch, and R. P. Novick. 1994. Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J. Bacteriol. 176:4204-4209.
23. Schlievert, P. M., J. R. Deringer, M. H. Kim, S. J. Projan, and R. P. Novick. 1992. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob. Agents Chemother. 36:626-631.
24. Schlievert, P. M., K. L. Strandberg, A. J. Brosnahan, M. L. Peterson, S. E. Pambuccian, K. R. Nephew, K. G. Brunner, N. J. Schultz-Darken, and A. T. Haase. 2008. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrob. Agents Chemother. 52:4448-4454.
25. Sobel, J. D. 2000. Bacterial vaginosis. Annu. Rev. Med. 51:349-356.
26. Sobel, J. D. 1985. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 152:924-935.
27. Sobel, J. D. 2007. Vulvovaginal candidosis. Lancet 369:1961-1971.
28. Thorsen, P., I. P. Jensen, B. Jeune, N. Ebbesen, M. Arpi, A. Bremmelgaard, and B. R. Moller. 1998. Few microorganisms associated with bacterial vaginosis may constitute the pathologic core: a population-based microbiologic study among 3596 pregnant women. Am. J. Obstet. Gynecol. 178:580-587.
29. Vetter, S. M., and P. M. Schlievert. 2005. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis. Antimicrob. Agents Chemother. 49:1302-1305.
30. Yamamoto, T., X. Zhou, C. J. Williams, A. Hochwalt, and L. J. Forney. 2009. Bacterial populations in the vaginas of healthy adolescent women. J. Pediatr. Adolesc. Gynecol. 22:11-18.